Story perspectives

Pharma Stocks Surge as Trump Exempts Tariffs

4/3/2025

29 5

Summary

Story summary

Pharmaceutical stocks rose sharply after President Trump exempted them from new tariffs, aiding Indian and European drugmakers.
Major firms like AstraZeneca and Novartis experienced gains, while Roche's stock fell due to a failed drug trial.
Analysts caution about potential future tariff risks, emphasizing the need to monitor US trade policies closely.
Indian pharma stocks surged, with the CNX Pharma index increasing over 3%, highlighting the US's importance for Indian generics.

1 of 1

Story summary

Pharmaceutical stocks rose sharply after President Trump exempted them from new tariffs, aiding Indian and European drugmakers.
Major firms like AstraZeneca and Novartis experienced gains, while Roche's stock fell due to a failed drug trial.
Analysts caution about potential future tariff risks, emphasizing the need to monitor US trade policies closely.
Indian pharma stocks surged, with the CNX Pharma index increasing over 3%, highlighting the US's importance for Indian generics.